Indiscriminately ordering blood tests for rare heparin reaction can lead to patient harm and increased costs
Testing for rare heparin reaction is unnecessary for most cases and can be potentially harmful and lead to increased costs, according to an article published in JAMA Internal Medicine.
Apr 28, 2016
0
3